Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine.
Stefania ForcinitiElisa Dalla PozzaMaria Raffaella GrecoTiago Miguel Amaral CarvalhoBarbara RolandoGiulia AmbrosiniCristian Andres Carmona-CarmonaRaffaella PacchianaDaria Di MolfettaMassimo DonadelliSilvia ArpiccoMarta PalmieriStephan Joel ReshkinIlaria DandoRosa Angela CardonePublished in: International journal of molecular sciences (2020)
We propose C18GEM together with autophagy inhibitors as a valid alternative therapeutic approach in PDAC treatment.